clofibrate has been researched along with sphingosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Carfagna, MA; Susick, RL; Young, KM | 1 |
| Amin, S; Plano, D; Sharma, AK | 1 |
1 review(s) available for clofibrate and sphingosine
| Article | Year |
|---|---|
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
Topics: Clofibrate; Drug Combinations; Enzyme Inhibitors; Humans; Isoenzymes; Lysophospholipids; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Practolol; Sphingosine | 2014 |
2 other study(ies) available for clofibrate and sphingosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Sex differences in rat hepatic cytolethality of the protein kinase C inhibitor safingol: role of biotransformation.
Topics: Administration, Oral; Animals; Biotransformation; Cell Count; Cell Death; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Clofibrate; Cytochrome P-450 Enzyme Inhibitors; DNA; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Liver; Liver Diseases; Male; Protein Kinase C; Rats; Rats, Inbred Strains; Sex Factors; Skin; Sphingosine; Time Factors | 1996 |